MedPath

Evaluation of the Radiological Dose Delivered to Risky Interventional Cardiology Patients (Optidose)

Conditions
X-rays; Effects
Chronic Total Occlusion
Interventions
Radiation: Gafchromic film
Registration Number
NCT05111496
Lead Sponsor
Ramsay Générale de Santé
Brief Summary

The purpose of this study is therefore to study the actual doses of X-rays delivered to the patient's skin during recanalization of a coronary artery in a context of Chronic Total Occlusion

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
85
Inclusion Criteria
  • Patient over 18 years-old
  • Patient requiring intervention with a predicted risk of exceeding the radiological threshold (Air Kerma> 3Gy): complex coronary dilation, coronary recanalization
  • Patient benefiting from a social protection insurance
  • Patient having been informed and not objecting to this research
Exclusion Criteria
  • Patient refusal to participate in the study
  • Patient with known radiosensitivity factors (eg: Lupus)
  • Patient having had radiotherapy treatment of the thoracic region.
  • Patient whose sum of radiation doses to the skin> 0.5 Gy in the thoracic region in the 3 months preceding inclusion.
  • Patient participating in another clinical study
  • Protected patient: adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
  • Pregnant or breastfeeding woman
  • Patient hospitalized without consent.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patient requiring intervention (complex coronary dilation or coronary recanalization)Gafchromic filmPatient requiring intervention with a predicted risk of exceeding the radiological threshold (Air Kerma\> 3Gy): complex coronary dilation, coronary recanalization
Primary Outcome Measures
NameTimeMethod
Dose measured to the patient's skin at the entrance to the X-ray beam1 month

Dose expressed in Gy (Peak skin dose).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hôpital privé La Louvière

🇫🇷

Lille, Haut De France, France

© Copyright 2025. All Rights Reserved by MedPath